SCHEMBL10739962

SCHEMBL10739962

CC1=C(C(=O)O)N2C(=O)C(NC(=O)C(=NOCCNC(=O)OC(C)(C)C)c3csc(NC=O)n3)[C@@H]2SC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 6/20 0.49
▸ APAF1 O14727 2/20 0.49
▸ APEX1 P27695 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ PLCG1 P19174 1/20 0.49
▸ ABCC2 Q92887 1/20 0.49
▸ SIRT5 Q9NXA8 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ PSMD14 O00487 1/20 0.48
▸ MMP2 P08253 1/20 0.48
▸ PTGS1 P23219 1/20 0.48
▸ NR1I2 O75469 5/20 0.47
▸ HTR2C P28335 1/20 0.47
▸ MAPT P10636 4/20 0.45
▸ PPARG P37231 3/20 0.45
▸ SLC22A6 Q4U2R8 2/20 0.45
▸ SLC22A8 Q8TCC7 2/20 0.45
▸ SLC22A11 Q9NSA0 2/20 0.45
▸ ALB P02768 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10739955 1.00 TDP1 (0.49) TDP1APAF1APEX1LMNATSHR
SCHEMBL10912586 0.93 TDP1 (0.48) TDP1APAF1APEX1LMNATSHR
SCHEMBL10912588 0.93 TDP1 (0.48) TDP1APAF1APEX1LMNATSHR
SCHEMBL10741508 0.89 NR1I2 (0.54) TDP1APAF1APEX1LMNATSHR
SCHEMBL10743442 0.89 NR1I2 (0.54) TDP1APAF1APEX1LMNATSHR
SCHEMBL10912175 0.89 TDP1 (0.47) TDP1APAF1APEX1LMNATSHR
SCHEMBL10912180 0.89 TDP1 (0.47) TDP1APAF1APEX1LMNATSHR
SCHEMBL11006705 0.88 TDP1 (0.54) TDP1APAF1APEX1LMNATSHR
SCHEMBL11006700 0.88 TDP1 (0.54) TDP1APAF1APEX1LMNATSHR
SCHEMBL10912102 0.87 NR1I2 (0.55) TDP1APAF1APEX1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4698337-A Cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-10-06 — — US disclosed
Send feedback